Reported 1 day ago
Moderna's stock surged over 10% on Tuesday, leading S&P 500 gains, after a reported bird flu death in the U.S. The biotech firm is working on an H5N1 vaccine. Despite this rise, Moderna shares have plummeted more than 55% over the past year.
Source: YAHOO